Merck Sharp & Dohme LLC /
Harpoon Therapeutics, Inc.
Merck Sharp & Dohme LLC completes acquisition of Harpoon Therapeutics, Inc.
What happened
Merck Sharp & Dohme LLC completed its acquisition of Harpoon Therapeutics, Inc. on March 11, 2024. Harpoon became a wholly owned subsidiary of Merck.
Harpoon common stockholders were entitled to receive $23.00 in cash per share.
The source
Everything on this page comes from the source below.
Merck Sharp & Dohme LLC completes acquisition of Harpoon Therapeutics, Inc.
This document is the source for the companies, stage and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Closed
The source this page is built from.
Source-verifiedPublished by the source
The source this page is built from.
Source-verified
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly